https://9krapalm.com/innovent-announces-primary-endpoint-met-in-the-second-phase-2-clinical-trial-of-ibi302-anti-vegf-complement-in-treating-neovascular-age-related-macular-degeneration-namd/ เสิร์ฟข่าวไอที อัปเดตเทคโนโลยีสไตล์ @krapalm Tue, 19 Mar 2024 00:49:39 +0000 hourly 1 https://wordpress.org/?v=7.0.2